Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Flour × Clear all

Phase

Phase NA 3 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Insulin Resistance 1 Hypoglycemia 1

Interventions

Cyclophosphamide 552 pembrolizumab 430 Paclitaxel 392 Gemcitabine 375 Cisplatin 373 Carboplatin 369 Radiotherapy 332 fludarabine 314 Nivolumab 296 Bevacizumab 241 Docetaxel 239 Irinotecan 216 Magnetic Resonance Spectroscopy 210 Dexamethasone 197 Specimen Handling 193 Fluorouracil 192 Capecitabine 189 Cytarabine 180 Rituximab 177 fludarabine phosphate 172 Oxaliplatin 170 Temozolomide 169 Biopsy 169 Ipilimumab 164 Etoposide 158 Lenalidomide 157 Doxorubicin 150 Cetuximab 150 Radiation 145 Bortezomib 145

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00970541 2021-08-25

Eccentric

Pennington Biomedical Research Center

Phase 1 Terminated

Hypoglycemia, Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡